Search Results - "Freeman, Dan"

Overcoming Beneficiary Race as an Impediment to Charitable Donations: Social Dominance Orientation, the Experience of Moral Elevation, and Donation Behavior by Freeman, Dan, Aquino, Karl, McFerran, Brent

“…Three studies examined the relationship between social dominance orientation (SDO), the experience of moral elevation, and Whites' donations to charitable…”
Get full text

Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors by D’Angelo, Noel D, Kim, Tae-Seong, Andrews, Kristin, Booker, Shon K, Caenepeel, Sean, Chen, Kui, D’Amico, Derin, Freeman, Dan, Jiang, Jian, Liu, Longbin, McCarter, John D, San Miguel, Tisha, Mullady, Erin L, Schrag, Michael, Subramanian, Raju, Tang, Jin, Wahl, Robert C, Wang, Ling, Whittington, Douglas A, Wu, Tian, Xi, Ning, Xu, Yang, Yakowec, Peter, Yang, Kevin, Zalameda, Leeanne P, Zhang, Nancy, Hughes, Paul, Norman, Mark H

“…Phosphoinositide 3-kinase α (PI3Kα) is a lipid kinase that plays a key regulatory role in several cellular processes. The mutation or amplification of this…”
Get full text

Genetic background controls tumor development in PTEN-deficient mice by Freeman, Dan, Lesche, Ralf, Kertesz, Nathalie, Wang, Shungyou, Li, Gang, Gao, Jing, Groszer, Matthias, Martinez-Diaz, Hilda, Rozengurt, Nora, Thomas, George, Liu, Xin, Wu, Hong

“…PTEN is one of the most frequently mutated tumor suppressor genes in human cancers. Germ line mutations of PTEN have been detected in three rare…”
Get full text

Advancing a participatory approach for youth risk behavior: Foundations, distinctions, and research directions by Mason, Marlys J., Tanner, John F., Piacentini, Maria, Freeman, Dan, Anastasia, Trena, Batat, Wided, Boland, Wendy, Canbulut, Murad, Drenten, Jenna, Hamby, Anne, Rangan, Priyam, Yang, Zhiyong

“…Researchers of youth risk behavior frequently assume that behavior is volitional; the choice is to either engage in a risky behavior or a safe alternative…”
Get full text

PTEN Deletion Leads to Up-regulation of a Secreted Growth Factor Pleiotrophin by Li, Gang, Hu, Yingchun, Huo, Yanying, Liu, Minli, Freeman, Dan, Gao, Jing, Liu, Xin, Wu, De-Chang, Wu, Hong

“…Tumor suppressor gene PTEN is highly mutated in a wide variety of human tumors. To identify unknown targets or signal transduction pathways that are regulated…”
Get full text

Beyond Moral Reasoning: A Review of Moral Identity Research and Its Implications for Business Ethics by Shao, Ruodan, Aquino, Karl, Freeman, Dan

“…Moral identity has been touted as a foundation for understanding moral agency in organizations. The purpose of this article is to review the current state of…”
Get full text

Entrepreneurial Leadership Across Contexts: Unique Challenges and Skills by Freeman, Dan

Get full text

Mangroves and Maneaters by Freeman, Dan

“…This is an action-packed book full of anecdotal adventure as the author, a professional zoologist, takes readers on his journeys to find wildlife around the…”
Get full text

Testing a Social-Cognitive Model of Moral Behavior: The Interactive Influence of Situations and Moral Identity Centrality by Aquino, Karl, Freeman, Dan, Reed, Americus, Lim, Vivien K. G, Felps, Will

“…This article proposes and tests a social-cognitive framework for examining the joint influence of situational factors and the centrality of moral identity on…”
Get full text

Long noncoding RNA SNHG12 integrates a DNA-PK-mediated DNA damage response and vascular senescence by Haemmig, Stefan, Yang, Dafeng, Sun, Xinghui, Das, Debapria, Ghaffari, Siavash, Molinaro, Roberto, Chen, Lei, Deng, Yihuan, Freeman, Dan, Moullan, Norman, Tesmenitsky, Yevgenia, Wara, A K M Khyrul, Simion, Viorel, Shvartz, Eugenia, Lee, James F, Yang, Tianlun, Sukova, Galina, Marto, Jarrod A, Stone, Peter H, Lee, Warren L, Auwerx, Johan, Libby, Peter, Feinberg, Mark W

“…Long noncoding RNAs (lncRNAs) are emerging regulators of biological processes in the vessel wall; however, their role in atherosclerosis remains poorly…”
Get more information

A grotesque and dark beauty: How moral identity and mechanisms of moral disengagement influence cognitive and emotional reactions to war by Aquino, Karl, Reed, Americus, Thau, Stefan, Freeman, Dan

“…Two studies examine the extent to which moral identity and moral disengagement jointly drive reactions to war. Study 1 finds support for a hypothesized…”
Get full text

Terraflow, a New High Parameter Data Analysis Tool, Reveals Systemic T-Cell Exhaustion and Dysfunctional Cytokine Production in Classical Hodgkin Lymphoma by Freeman, Dan, Lam, Linda, Li, Tri, Alexandre, Jason, Raphael, Bruce G., Kaminetzky, David, Ruan, Jia, Chattopadhyay, Pratip, Diefenbach, Catherine S.

“…Background Classical Hodgkin lymphoma (cHL) is characterized by rare, malignant Hodgkin/Reed Sternberg (HRS) cells that shape their microenvironment (TME) to…”
Get full text

Impact of a TeamSTEPPS Trauma Nurse Academy at a Level 1 Trauma Center by Peters, V. Kristen, Harvey, Ellen M., Wright, Andi, Bath, Jennifer, Freeman, Dan, Collier, Bryan

“…Nurses are crucial members of the team caring for the acutely injured trauma patient. Until recently, nurses and physicians gained an understanding of…”
Get full text

Entrepreneurial Leadership in the Context of Company Start-Up and Growth by Freeman, Dan, Siegfried Jr, Robert L.

“…Starting a new business is easy. Leading a start‐up and transitioning from founder to CEO is hard. As a result, less than 1 in 25 new companies will grow to…”
Get full text

Abstract 3627: Volrustomig a novel PD-1/CTLA-4 bispecific antibody leads to robust increase in peripheral and intra-tumoral pharmacodynamic biomarkers in solid tumors from FTiH study by Achour, Ikbel, Kuziora, Michael, Song, Florian, Eck, Steven, Meinecke, Lina, Blando, Jorge, Pearson, Jennifer, Saraiya, Megha, Eisen, Christian, Segerer, Felix, Schick, Markus, Triltsch, Nicolas, Surace, Michael, Boos, Gisele Silva, Hessel, Harald, Bui, Mai, Pratsch, Katrin, Andoni, Alma, Gainer, Shelby Denise, Freeman, Dan, Subramaniam, Deepa, Tran, Ben

“…Abstract Background: Volrustomig (MEDI5752) is designed to fully inhibit PD-1 while preferentially inhibiting CTLA-4 on activated PD-1+ T cells. In a FTiH…”
Get full text

Thromboelastography in healthy dairy cows by Sommerey, Cora-Costanze, Williams, Tim L, McCrone, Ian, Ruiz-Ferreras, Aran, Freeman, Dan, Archer, Joy

“…Thromboelastography is a whole blood-based coagulation assay that can be used to investigate hypocoagulability and hypercoagulability, as seen with…”
Get more information

Memory issues pertaining to social marketing messages about behavior enactment versus non-enactment by Freeman, Dan, Shapiro, Stewart, Brucks, Merrie

“…This article examines efficiency issues pertaining to social marketing messages about behavior enactment (e.g., smoker) vs. non-enactment (e.g., nonsmoker)…”
Get full text

Abstract CT016: MEDI5752, a novel PD-1/CTLA-4 bispecific checkpoint inhibitor for advanced solid tumors: First-in-human study by Tran, Ben, Voskoboynik, Mark, Kim, Sang-We, Lemech, Charlotte, Carcereny, Enric, Rha, Sun Young, Ahn, Myung-Ju, Felip, Enriqueta, Lee, Ki H., Alvarez, Eduardo C., Yang, James Chih-Hsin, Ascierto, Paolo A., Pulla, Mariano P., Freeman, Dan, Song, Xuyang, Gainer, Shelby D., Mitchell, Patrick, Achour, Ikbel, Subramaniam, Deepa S., Im, Seock-Ah

“…Abstract Background: MEDI5752 is a monovalent bispecific antibody targeting PD-1 and CTLA-4. The bispecific format is engineered to preferentially inhibit…”
Get full text

Youths' understandings of cigarette advertisements by Freeman, Dan, Brucks, Merrie, Wallendorf, Melanie, Boland, Wendy

“…Abstract This study addresses two questions: (1) when youths are exposed to advertisements for cigarettes, do they primarily see advertisements for brands or…”
Get full text

Abstract B171: U3-1287 (AMG 888), a fully human anti-HER3 mAb, demonstrates in vitro and in vivo efficacy in NSCLC models by Freeman, Dan, Ogbagabriel, Selam, Schneider, Matthias, Radinsky, Robert, Hettman, Thore

“…Abstract Background: EGFR TKIs have demonstrated activity in NSCLC, however most patients are resistant or acquire resistance to therapy. HER3 is a member of…”
Get full text